Skip to main content

Advertisement

SpringerLink
Log in

Galectin-3, a damage-associated molecular pattern, in tears of patients with vernal keratoconjunctivitis

  • Laboratory Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

Galectin-3 is a damage-associated molecular pattern (DAMPs), released from damaged or dying cells. In this study, we investigated the concentration and source of galectin-3 in the tears of patients with vernal keratoconjunctivitis (VKC) and evaluated whether the concentration of galectin-3 in tears represents a biomarker of corneal epithelial damage.

Study design

Clinical and experimental.

Methods

We measured the concentration of galectin-3 in tear samples from 26 patients with VKC and 6 healthy controls by enzyme-linked immunosorbent assay (ELISA). The expression of galectin-3 in cultured human corneal epithelial cells (HCEs) stimulated with or without tryptase or chymase was investigated by polymerase chain reaction (PCR), ELISA, and Western blotting. We also estimated the concentration of galectin-3 in the supernatants of cultured HCEs induced to necrosis. Finally, we investigated whether recombinant galectin-3 induced the expression of various genes related to cell migration or the cell cycle in HCEs by using microarray analysis.

Results

High concentrations of galectin-3 were detected in the tears of patients with VKC. The concentration showed significant correlation with the severity of corneal epithelial damage. Stimulation of cultured HCEs with various concentrations of tryptase or chymase had no effect on the expression of galectin-3. However, high concentrations of galectin-3 were detected in the supernatants of necrotic HCEs. Recombinant human galectin-3 induced various cell migration- and cell cycle-related genes.

Conclusion

The concentrations of galectin-3 in the tears of patients with VKC may represent a biomarker of the severity of corneal epithelial damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F. Introduction to galectins. Glycoconj J. 2002;19:433–40.

    Article  CAS  PubMed  Google Scholar 

  2. Liu FT, Rabinovich GA. Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci. 2010;1183:158–82.

    Article  CAS  PubMed  Google Scholar 

  3. Frigeri LG, Liu FT. Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol. 1992;148:861–7.

    Article  CAS  PubMed  Google Scholar 

  4. Liu FT, Frigeri LG, Gritzmacher CA, Hsu DK, Robertson MW, Zuberi RI. Expression and function of an IgE-binding animal lectin (epsilon BP) in mast cells. Immunopharmacology. 1993;26:187–95.

    Article  CAS  PubMed  Google Scholar 

  5. Frigeri LG, Zuberi RI, Liu FT. Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells. Biochemistry. 1993;32:7644–9.

    Article  CAS  PubMed  Google Scholar 

  6. Zuberi RI, Frigeri LG, Liu FT. Activation of rat basophilic leukemia cells by epsilon BP, an IgE-binding endogenous lectin. Cell Immunol. 1994;156:1–12.

    Article  CAS  PubMed  Google Scholar 

  7. Craig SS, Krishnaswamy P, Irani AM, Kepley CL, Liu FT, Schwartz LB. Immunoelectron microscopic localization of galectin-3, an IgE binding protein, in human mast cells and basophils. Anat Rec. 1995;242:211–9.

    Article  CAS  PubMed  Google Scholar 

  8. Brewer CF, Miceli MC, Baum LG. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol. 2002;12:616–23.

    Article  CAS  PubMed  Google Scholar 

  9. Rabinovich GA, Toscano MA, Jackson SS, Vasta GR. Functions of cell surface galectin-glycoprotein lattices. Curr Opin Struct Biol. 2007;17:513–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dumic J, Dabelic S, Flögel M. Galectin-3: an open-ended story. Biochim Biophys Acta. 2006;1760:616–35.

    Article  CAS  PubMed  Google Scholar 

  11. Ahmad N, Gabius HJ, André S, Kaltner H, Sabesan S, Roy R, et al. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem. 2004;279:10841–7.

    Article  CAS  PubMed  Google Scholar 

  12. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, et al. Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008;180:2650–8.

    Article  CAS  PubMed  Google Scholar 

  13. Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA. 2006;103:5060–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Nishi Y, Sano H, Kawashima T, Okada T, Kuroda T, Kikkawa K, et al. Role of galectin-3 in human pulmonary fibrosis. Allergol Int. 2007;56:57–65.

    Article  CAS  PubMed  Google Scholar 

  15. Newlaczyl AU, Yu LG. Galectin-3–a jack-of-all-trades in cancer. Cancer Lett. 2011;313:123–8.

    Article  CAS  PubMed  Google Scholar 

  16. Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol. 2012;60:1249–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Riccio AM, Mauri P, De Ferrari L, Rossi R, Di Silvestre D, Benazzi L, et al. Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months. Clin Transl Allergy. 2017;7:6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Koufakis DI, Karabatsas CH, Sakkas LI, Alvanou A, Manthos AK, Chatzoulis DZ. Conjunctival surface changes in patients with Sjogren’s syndrome: a transmission electron microscopy study. Invest Ophthalmol Vis Sci. 2006;47:541–4.

    Article  PubMed  Google Scholar 

  19. Danjo Y, Watanabe H, Tisdale AS, George M, Tsumura T, Abelson MB, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci. 1998;39:2602–9.

    CAS  PubMed  Google Scholar 

  20. Uchino Y, Mauris J, Woodward AM, Dieckow J, Amparo F, Dana R, et al. Alteration of galectin-3 in tears of patients with dry eye disease. Am J Ophthalmol. 2015;159:1027-35.e3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ge XN, Ha SG, Liu FT, Rao SP, Sriramarao P. Eosinophil-expressed galectin-3 regulates cell trafficking and migration. Front Pharmacol. 2013;4:37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rao SP, Wang Z, Zuberi RI, Sikora L, Bahaie NS, Zuraw BL, et al. Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow. J Immunol. 2007;179:7800–7.

    Article  CAS  PubMed  Google Scholar 

  23. Han JL, Ding RY, Zhao L, Ren Z, Jiang XJ. Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis. J Int Med Res. 2008;36:830–6.

    Article  CAS  PubMed  Google Scholar 

  24. Zuberi RI, Hsu DK, Kalayci O, Chen HY, Sheldon HK, Yu L, et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol. 2004;165:2045–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ge XN, Bahaie NS, Kang BN, Hosseinkhani MR, Ha SG, Frenzel EM, et al. Allergen-induced airway remodeling is impaired in galectin-3-deficient mice. J Immunol. 2010;185:1205–14.

    Article  CAS  PubMed  Google Scholar 

  26. del Pozo V, Rojo M, Rubio ML, Cortegano I, Cárdaba B, Gallardo S, et al. Gene therapy with galectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through interleukin-5 gene downregulation. Am J Respir Crit Care Med. 2002;166:732–7.

    Article  PubMed  Google Scholar 

  27. López E, Zafra MP, Sastre B, Gámez C, Lahoz C, del Pozo V. Gene expression profiling in lungs of chronic asthmatic mice treated with galectin-3: downregulation of inflammatory and regulatory genes. Mediators Inflamm. 2011;2011: 823279.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Saegusa J, Hsu DK, Chen HY, Yu L, Fermin A, Fung MA, et al. Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis. Am J Pathol. 2009;174:922–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hrdlicková-Cela E, Plzák J, Smetana K Jr, Mĕlková Z, Kaltner H, Filipec M, et al. Detection of galectin-3 in tear fluid at disease states and immunohistochemical and lectin histochemical analysis in human corneal and conjunctival epithelium. Br J Ophthalmol. 2001;85:1336–40.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Andrade FEC, Covre JL, Ramos L, Hazarbassanov RM, Santos MSD, Campos M, et al. Evaluation of galectin-1 and galectin-3 as prospective biomarkers in keratoconus. Br J Ophthalmol. 2018;102:700–7.

    Article  PubMed  Google Scholar 

  31. Andrade FEC, Corrêa MP, Gimenes AD, Dos Santos MS, Campos M, Chammas R, et al. Galectin-3: role in ocular allergy and potential as a predictive biomarker. Br J Ophthalmol. 2018;102:1003–10.

    Article  PubMed  Google Scholar 

  32. Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, et al. Japanese guidelines for allergic conjunctival diseases 2017. Allergol Int. 2017;66:220–9.

    Article  PubMed  Google Scholar 

  33. Ebihara N, Matsuda A, Nakamura S, Matsuda H, Murakami A. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing. Invest Ophthalmol Vis Sci. 2011;52:8549–57.

    Article  CAS  PubMed  Google Scholar 

  34. Ochieng J, Fridman R, Nangia-Makker P, Kleiner DE, Liotta LA, Stetler-Stevenson WG, et al. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry. 1994;33:14109–14.

    Article  CAS  PubMed  Google Scholar 

  35. Nangia-Makker P, Raz T, Tait L, Hogan V, Fridman R, Raz A. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. Cancer Res. 2007;67:11760–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Ebihara N, Funaki T, Takai S, Miyazaki M, Fujiki K, Murakami A. Tear chymase in vernal keratoconjunctivitis. Curr Eye Res. 2004;28:417–20.

    Article  PubMed  Google Scholar 

  37. Matzinger P. The danger model: a renewed sense of self. Science. 2002;296:301–5.

    Article  CAS  PubMed  Google Scholar 

  38. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol. 2005;17:359–65.

    Article  CAS  PubMed  Google Scholar 

  39. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1–5.

    Article  CAS  PubMed  Google Scholar 

  40. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007;13:851–6.

    Article  CAS  PubMed  Google Scholar 

  41. Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet. 1982;2:11–6.

    Article  CAS  PubMed  Google Scholar 

  42. Pégorier S, Wagner LA, Gleich GJ, Pretolani M. Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol. 2006;177:4861–9.

    Article  PubMed  Google Scholar 

  43. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med. 1985; 313:282-5.

  44. Omoto M, Gu LH, Sugiura H, Uehara M. Heterogeneity of dermal deposition of eosinophil granule major basic protein in acute lesions of atopic dermatitis. Arch Dermatol Res. 2000;292:51–4.

    Article  CAS  PubMed  Google Scholar 

  45. Secchi A, Leonardi A, Abelson M. The role of eosinophil cationic protein (ECP) and histamine in vernal keratoconjunctivitis. Ocul Immunol Inflamm. 1995;3:23–8.

    Article  CAS  PubMed  Google Scholar 

  46. Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy. 1995;50:610–3.

    Article  CAS  PubMed  Google Scholar 

  47. Pucci N, Novembre E, Lombardi E, Cianferoni A, Bernardini R, Massai C, et al. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms. Clin Exp Allergy. 2003;33:325–30.

    Article  CAS  PubMed  Google Scholar 

  48. Saravanan C, Liu FT, Gipson IK, Panjwani N. Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin. J Cell Sci. 2009;122:3684–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Yabuta C, Yano F, Fujii A, Shearer TR, Azuma M. Galectin-3 enhances epithelial cell adhesion and wound healing in rat cornea. Ophthalmic Res. 2014;51:96–103.

    Article  CAS  PubMed  Google Scholar 

  50. Cao Z, Said N, Amin S, Wu HK, Bruce A, Garate M, et al. Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds. J Biol Chem. 2002;277:42299–305.

    Article  CAS  PubMed  Google Scholar 

  51. Saravanan C, Cao Z, Head SR, Panjwani N. Detection of differentially expressed wound-healing-related glycogenes in galectin-3-deficient mice. Invest Ophthalmol Vis Sci. 2009;50:5690–6.

    Article  PubMed  Google Scholar 

  52. Fujii A, Shearer TR, Azuma M. Galectin-3 enhances extracellular matrix associations and wound healing in monkey corneal epithelium. Exp Eye Res. 2015;137:71–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Mauris J, Woodward AM, Cao Z, Panjwani N, Argüeso P. Molecular basis for MMP9 induction and disruption of epithelial cell-cell contacts by galectin-3. J Cell Sci. 2014;127:3141–8.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Juntendo University Graduate School of Medicine, Tokyo, Japan

    Yousuke Ito

  2. Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1, Tomioka, Urayasu-shi, Chiba, Japan

    Yousuke Ito, Ayumi Usui-Ouchi & Nobuyuki Ebihara

Authors
  1. Yousuke Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayumi Usui-Ouchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobuyuki Ebihara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nobuyuki Ebihara.

Ethics declarations

Conflicts of interest

Y. Ito, None; A. U-Ouchi, None; N. Ebihara, None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Corresponding Author: Nobuyuki Ebihara

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, Y., Usui-Ouchi, A. & Ebihara, N. Galectin-3, a damage-associated molecular pattern, in tears of patients with vernal keratoconjunctivitis. Jpn J Ophthalmol 67, 431–439 (2023). https://doi.org/10.1007/s10384-023-00994-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-023-00994-9

Keywords

Search

Navigation